Somahlution Inc - Product Pipeline Analysis, 2018 Update

  • ID: 4267311
  • Company Profile
  • 27 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • 3M Unitek
  • 7 Medical Systems LLC
  • Advanced ICU Care Inc
  • MORE
Summary

Somahlution Inc (Somahlution) is a biotechnology company that offers discovery, development and commercialization of innovative solutions to advance clinical performance. The company provides duragraft, a vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure. It offers research and development approach, product pipeline management, clinical trials, initiated trial and education services. Somahlution provides solutions in the areas of ischemia reperfusion injury, organ and tissue transplantation, cardiothoracic and vascular surgery and renal dialysis. The company’s products are used in ischemia reperfusion injury, coronary artery bypass surgery, PCI, peripheral vascular bypass surgery and organ transplantation applications. Somahlution is headquartered in Jupiter, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Somahlution Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M Unitek
  • 7 Medical Systems LLC
  • Advanced ICU Care Inc
  • MORE
  • Somahlution Inc Company Overview
  • Somahlution Inc Company Snapshot
  • Somahlution Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Somahlution Inc - Pipeline Analysis Overview
  • Somahlution Inc - Key Facts
  • Somahlution Inc - Major Products and Services
  • Somahlution Inc Pipeline Products by Development Stage
  • Somahlution Inc Ongoing Clinical Trials by Trial Status
  • Somahlution Inc Pipeline Products Overview
  • Duragraft
  • Duragraft Product Overview
  • Duragraft Clinical Trial
  • SOM-Heart
  • SOM-Heart Product Overview
  • SOM-Kidney
  • SOM-Kidney Product Overview
  • SOM-Liver
  • SOM-Liver Product Overview
  • SOM-Lung
  • SOM-Lung Product Overview
  • Somahlution Inc - Key Competitors
  • Somahlution Inc - Key Employees
  • Somahlution Inc - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Somahlution Inc, Recent Developments
  • Feb 13, 2018: Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraft Registry
  • May 30, 2017: Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany
  • May 05, 2017: Somahlution Announces Medical University of Vienna as First Austrian Site to Participate in DuraGraft Registry
  • Feb 01, 2017: Somahlution Announces Multiple Site Initiation and Patient Enrollment in Spain for European DuraGraft Registry
  • Jan 04, 2017: Somahlution Announces Patient Enrollment In Duragraft CABG European Registry
  • Oct 04, 2016: Somahlution Announces Study Results Showing DuraGraft Vascular Graft Treatment Improves Long-Term Outcomes in Coronary Artery Bypass Grafting Surgery
  • Jan 06, 2016: Somahlution Announces Collaboration with Owens & Minor's Movianto Group To Provide Global Warehousing Services
  • Oct 29, 2015: DuraGraft Makes a Strong Impression at the EACTS Annual Meeting in Amsterdam during Satellite Symposium Featuring Dr. John R. Pepper
  • Sep 09, 2015: Dr. Louis Perrault Presents Design and Progression of Prospective DuraGraft Study During Recent AATS International Coronary Congress
  • Mar 25, 2015: Somahlution Announces New Global Distribution Partnerships For Duragraft Vascular Conduit Solution
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Somahlution Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Somahlution Inc Pipeline Products by Equipment Type
  • Somahlution Inc Pipeline Products by Indication
  • Somahlution Inc Ongoing Clinical Trials by Trial Status
  • Somahlution Inc, Key Facts
  • Somahlution Inc, Major Products and Services
  • Somahlution Inc Number of Pipeline Products by Development Stage
  • Somahlution Inc Pipeline Products Summary by Development Stage
  • Somahlution Inc Ongoing Clinical Trials by Trial Status
  • Somahlution Inc Ongoing Clinical Trials Summary
  • Duragraft - Product Status
  • Duragraft - Product Description
  • Duragraft - European (EU) Multi-center Registry to Assess Outcomes in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: Treatment of Vascular Conduits with Duragraft, a Novel Endothelial Damage Inhibitor: VASC
  • SOM-Heart - Product Status
  • SOM-Heart - Product Description
  • SOM-Kidney - Product Status
  • SOM-Kidney - Product Description
  • SOM-Liver - Product Status
  • SOM-Liver - Product Description
  • SOM-Lung - Product Status
  • SOM-Lung - Product Description
  • Somahlution Inc, Key Employees
  • Glossary
List of Figures
  • Somahlution Inc Pipeline Products by Equipment Type
  • Somahlution Inc Pipeline Products by Development Stage
  • Somahlution Inc Ongoing Clinical Trials by Trial Status 9
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 7 Medical Systems LLC
  • Advanced ICU Care Inc
  • 3M Unitek
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll